HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 22, No 05, May 2018 – Dental health - The root to good health       » Drugs to watch 2018       » Dragonfly-inspired nano coating kills bacteria upon contact       » New compound improves stroke recovery in monkeys and mice       » Cancer stem cell therapy breakthrough       » Draft genome of tea plant sequenced      
BIOBOARD - INSIDE INDUSTRY
Biametrics successfully finalizes feasibility study with MorphoSys in the area of high-throughput antibody screening
Biametrics GmbH and MorphoSys AG plan to further collaborate in the area of high-throughput antibody screening.

Biametrics performed a very successful screening study using MorphoSys' reagents and Biametrics' label-free microarray based instrumentation b-screen for the characterization of Fab fragment antigen interactions. The feasibility study clearly demonstrated the advantages of b-screen to speed up the overall antibody screening process using the microarray format. Recently, Biametrics launched their b-screen device for high-throughput biomolecular interaction screening/analysis.

"We are delighted to be collaborating with MorphoSys, a leader in the development of biotherapeutics," said Dr. Florian Pröll, Managing Director of Biametrics "We look forward to expand our collaboration in the field of biomolecular interaction analysis."

Biametrics' b-screen device enables the detection of these biomolecules in a high-density array format on microscope slide disposables. Thereby, no fluorescence labels are needed for read-out. This leads to minimized sample pre-treatment and reagent consumption. With this new optical detection method, it is possible to reduce the complexity of the conventional label-free assays while enhancing the throughput and maintaining precision and reliability.

"We have identified b-screen as an promising technology in the field of epitope mapping, and will now broaden our collaboration with Biametrics", added Dr. Markus Enzelberger, Senior VP, Head of Discovery Alliances & Technologies at MorphoSys AG.

The collaboration between MorphoSys AG as a globally established supplier of therapeutic antibodies and Biametrics as an aspiring technology company allows for a fast and successful development of such biopharmaceuticals. MorphoSys will continue the cooperation with Biametrics.

Source: B3C Newswire

Click here for the complete issue.

NEWS CRUNCH  
news Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases
news EmTech Asia explores future of life, humanity and economy
news Biology of Ageing II - Impactful Interventions
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2018
January:
Obesity / Outlook for 2018
February:
Searching for the fountain of youth
March:
Women in Science - Making a difference
April:
Digestive health in the 21st century - Trust your guts
May:
Dental health - The root to good health
June:
Oncology / Biotech landscape in APAC
July:
Water management / Vaccination
August:
Regenerative medicine / Biotech start ups
September:
Digital healthcare / 3D printing
October:
Bones / Breast cancer
November:
Liver health / Top science research nations & institutions
December:
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy